Consumer Products
Retail
US

Marker Therapeutics

$5.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-8.79%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!

About MRKR

Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Read More The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Employees
11
Headquarters
Houston, Texas
Founded
1991
Market Cap
274.27M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.11M
High Today
$5.88
Low Today
$5.43
Open Price
$5.81
Volume
1.24M
52 Week High
$10.60
52 Week Low
$4.18

Collections

Consumer Products
Retail
US
North America

MRKR Earnings

Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.